Correlation Between Rezolute and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rezolute and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Rezolute and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Pasithea Therapeutics.
Diversification Opportunities for Rezolute and Pasithea Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Rezolute and Pasithea is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Rezolute i.e., Rezolute and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Rezolute and Pasithea Therapeutics
Given the investment horizon of 90 days Rezolute is expected to generate 0.75 times more return on investment than Pasithea Therapeutics. However, Rezolute is 1.34 times less risky than Pasithea Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.03 per unit of risk. If you would invest 195.00 in Rezolute on December 12, 2024 and sell it today you would earn a total of 161.00 from holding Rezolute or generate 82.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rezolute vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Rezolute |
| Pasithea Therapeutics |
Rezolute and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rezolute and Pasithea Therapeutics
The main advantage of trading using opposite Rezolute and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.The idea behind Rezolute and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Pasithea Therapeutics vs. Nutriband Warrant | ||
| Pasithea Therapeutics vs. MediciNova | ||
| Pasithea Therapeutics vs. Virax Biolabs Group | ||
| Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |